Although many institutions conduct Phase II and III clinical trials, the UC Davis Comprehensive Cancer Center is the only institution in the Sacramento region with the infrastructure required to conduct Phase I clinical trials. The Sacramento Citywide Oncology Phase I program (SCOPE), established in 2015, is the community outreach component of the Phase I program that creates collaboration with physicians from Dignity Health, Kaiser Permanente, Sierra Hematology Oncology and Sutter Health to enroll patients in Phase I clinical trials.
Phase I clinical trials provide an additional treatment option for patients who have failed standard cancer therapies. At any given time, 50 or more Phase I clinical trials are underway at the UC Davis Comprehensive Cancer Center.
Patients are encouraged to ask their physician about their eligibility for UC Davis Comprehensive Cancer Center clinical trials appropriate for their type of cancer.
